ATAD1 and malaria: Several ELISA based studies have reported significant associations between levels of antibodies to MSP1-19 and protection from malaria [38], [40]–[42], [71]–[74]; a recent meta-analysis indicated a 19% reduction in malaria risk for individuals with MSP1-19 antibodies [20].